April 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

Drug Information Update Table of Contents First-Time Generics New Drug Entities New Indications FDA News/Bulletins/Advisories/Safety Alerts Studies Recalls Current Drug Shortages Page 3 Page 3-7 Page 7-8 Page 8-12 Page 12-20 Page 20-34 Page 34-79 2
First-Time Generics GENERIC DRUG NAME GENERIC MANUFACTURER BRAND NAME APPROVAL DATE B3/Azel AC/Zinc/B6/Copper/FA Virtus Pharmace Nicazel 02/24/2012 VIT B12/Lmefolate CA/VIT B6/B Virtus Pharmace Cerefolin 02/24/2012 Progesterone, Micronized Teva USA Prometrium 03/02/2012 Escitalopram Oxalate Mylan Lexapro 03/01/2012 Ziprasidone Hcl Major Pharma Geodon 03/06/2012 Calcitriol Perrigo Co. Vectical 03/02/2012 Doxorubicin Hcl Liposomal Sun Pharma Glob Doxil 03/02/2012 Escitalopram Oxalate Solution Amneal Pharma Lexapro Solution 03/16/2012 Emollient Combination No.44 Emollient Combination No. 53 Prugen Pharma Prugen Pharma Hylatopic Emollient Foam Hylatopic Plus Emollient Foam 03/23/2012 03/23/2012 Ibandronate Sodium Mylan Boniva 03/22/2012 Gruenhaupt, Mark R.Ph. Argus Health Systems, Inc. c2005 Available from: www.argushealth.com [cited March 15, 2012]. Gruenhaupt, Mark R.Ph. Argus Health Systems, Inc. c2005 Available from: www.argushealth.com [cited March 29, 2012]. New Drug Entities DESCRIPTION BRAND NAME GENERIC NAME STRENGTH NOTES PRENATAL VITAMIN PREPARATIONS VITAMED MD PLUS RX COMBO. PKG PRENATAL NO.39/IRON/FA#6/DHA 30-1-300MG New Combination LOCAL ANESTHETICS BUPI-VACAINE HCL- 0.9% NACL DISP SYRIN BUPIVACAINE HCL /0.9% NACL/ PF 50MG/ 20ML New Strength LOCAL ANESTHETICS ROPI-VACAINE HCL- 0.9% NACL DISP SYRIN ROPIVACAINE HCL IN 0.9% NACL/PF 100MG/ 20ML New Strength LOCAL ANESTHETICS BUPI-VACAINE HCL- 0.9% NACL DISP SYRIN BUPIVACAINE HCL /0.9% NACL/ PF 150MG/ 30ML New Strength ANALGESICS, NARCOTICS HYDROCODONE- ACETAMINOPHEN SOLUTION HYDROCODONE BIT/ ACETAMINOPHEN 7.5-325/ CP New Strength SYMPATHOMIMETIC AGENTS PHENYLEPHRINE HCL- D5W IV PLAST. BAG PHENYLEPHRINE HCL/ D5W/ PF 8 MG/ 100ML New Strength ANTI-PSORIATICS AGENTS ZITHRANOL SHAMPOO (G) ANTHRALIN MICRONIZED 1% New Dosage Form 3
Page 1: April 2012 Drug Information Update
Page 5 and 6: GENERAL ANESTHETICS, INJECTABLE MID
Page 7 and 8: Gruenhaupt, Mark R.Ph. Argus Health
Page 9 and 10: Statin Drugs - Drug Safety Communic
Page 11 and 12: Vytorin (ezetimibe/simvastatin) Tab
Page 13 and 14: low blood sugar (hypoglycemia) in p
Page 15 and 16: Some women with depression who beco
Page 17 and 18: Survival increased for all groups o
Page 19 and 20: finding that it also may reduce the
Page 21 and 22: Syringes (2 mL size), Rx only. NDC
Page 23 and 24: Patheon Pharmaceuticals Inc., Cinci
Page 25 and 26: 50-ct. bottles (NDC 0067-6238-50);
Page 27 and 28: PRODUCT (Class II) 1) Ventolin HFA
Page 29 and 30: Lot #: 0693, Exp: 10/2012 RECALLING
Page 31 and 32: 24 (Display case UPC# 3030045074923
Page 33 and 34: CODE Lot # 139961 RECALLING FIRM/MA
Page 35 and 36: Reason for the Shortage • Teva co
Page 37 and 38: Reason for the Shortage • Ben Ven
Page 39 and 40: Products Affected - Description Gan
Page 41 and 42: 37.5 mg/25 mg, 1000 count (NDC 0078
Page 43 and 44: Acyclovir tablets, Major 400 tablet
Page 45 and 46: 500 mg, 100 count (NDC 63304-0726-0
Page 47 and 48: 750 mg tablets, 100 count (NDC 1013
Page 49 and 50: • Bedford Laboratories has multip
Page 51 and 52: Daunorubicin Hydrochloride Injectio
Page 53 and 54:
Ciprofloxacin Immediate-Release Tab
Page 55 and 56:
• APP had tobramycin 40 mg/mL pre
Page 57 and 58:
• Ben Venue voluntarily suspended
Page 59 and 60:
50 mg/mL, 10 mL vial, package of 10
Page 61 and 62:
2 mL vial, preservative-free (NDC 6
Page 63 and 64:
5 mg single dose vial, package of 1
Page 65 and 66:
20 mL glass ampule, sterile pack (N
Page 67 and 68:
2 mL iSecure syringe (NDC 00406-112
Page 69 and 70:
Lidocaine 0.5% Xylocaine 0.5% injec
Page 71 and 72:
• Teva discontinued all ciproflox
Page 73 and 74:
Nicardipine hydrochloride injection
Page 75 and 76:
Article link: http://www.ashp.org/D
Page 77 and 78:
• Apotex had metformin products u
Page 79:
• Covis purchased all rights to F
show all

April 2012 Drug Information Update - Pharmacy Benefits ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?